Update on the Talent aortic stent-graft: A preliminary report from United States phase I and II trials

Criado, Frank J.; Wilson, Eric P.; Fairman, Ronald M.; Abul-Khoudoud, Omran; Wellons, Eric D.

doi:10.1067/mva.2001.111677

Cited by 92 publications

(49 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Diameter ranges are 16 to 36 mm for the aortic section and 8 to 22 mm for the iliac limbs. 31 The Zenith endograft has evolved from a worldwide collaborative effort that began in 1991. Observations of early complications associated with endovascular grafting have resulted in a series of modifications that led to the current system.…”

Section: Devicesmentioning

confidence: 99%

Suprarenal Fixation of Endograft in Abdominal Aortic Aneurysm Treatment

Grego

Frigatti²,

Antonello³

et al. 2004

Annals of Surgery

View full text Add to dashboard Cite

show abstract

Section: Devicesmentioning

confidence: 99%

Suprarenal Fixation of Endograft in Abdominal Aortic Aneurysm Treatment

Grego

Frigatti²,

Antonello³

et al. 2004

Annals of Surgery

View full text Add to dashboard Cite

show abstract

“…[3][4][5][6][7][8][9] To be effective, a stent-graft needs to maintain fixation, hemodynamic seal, mechanical integrity, and patency over many years. However, a stent-graft implanted in an aortic aneurysm is subjected to several adverse factors that tend to compromise these functions.…”

mentioning

confidence: 99%

Risk-Adjusted Outcome Analysis of Endovascular Abdominal Aortic Aneurysm Repair in a Large Population:How Do Stent-Grafts Compare?

Marrewijk

Leurs

Vallabhaneni

et al. 2005

Journal of Endovascular Therapy

116

View full text Add to dashboard Cite

ࡗ ࡗPurpose: To compare differences in the applicability and incidence of postoperative adverse events among stent-grafts used for repair of infrarenal aortic aneurysms.Methods: An analysis of 6787 patients from the EUROSTAR Registry database was conducted to compare aneurysm morphological features, patient characteristics, and postoperative events for the AneuRx, EVT/Ancure, Excluder, Stentor, Talent, and Zenith devices versus the Vanguard device (control) and each other. Annual incidence rates of complications were determined, and risks were compared using the Cox proportional hazards analysis. Results:The annual incidence rates were: device-related endoleak (types I and III) 6% (range 4%-10%), type II endoleak 5% (range 0.3%-11%), migration 3% (range 0.5%-5%), kinking 2% (range 1%-5%), occlusion 3% (range 1%-5%), rupture 0.5% (range 0%-1%), and all-cause mortality 7% (range 5%-8%). After adjustment for factors influencing outcome, AneuRx, Excluder, Talent, and Zenith devices were associated with a lower risk of migration, kinking, occlusion, and secondary intervention compared to the Vanguard device. Significant increased risk for conversion (EVT/Ancure) and reduced risk of aneurysm rupture (AneuRx and Zenith) and all-cause mortality (Excluder) were found compared to the Vanguard device. Conclusions: Significant differences exist between stent-grafts of different labels in terms of applicability and complications during intermediate to long-term follow-up. Since each stent-graft has its drawbacks, no single label can be identified as the best. It is reassuring that developments in stent-grafts indeed result in better performance than the early stentgrafts. However, a single device incorporating all the perceived improvements should still be pursued. J Endovasc Ther 2005;12:417-429

show abstract

“…(Although the Talent stent graft is made from Nitinol, it also possesses a balloon for inflation to insure total expansion of the stent, and to allow easy positioning. 36 ) Many stents, such as the Zenith, have initial partial deployment which allows partial repositioning; no repositioning can be performed when the graft is fully deployed. Most stents cannot be repositioned after deployment, and in some, such as the Excluder stent graft, the deployment system is designed to allow rapid expansion of the stent.…”

Section: Deployment Problems and Repositioningmentioning

confidence: 99%

AAA Stent–Grafts: Past Problems and Future Prospects

et al. 2010

View full text Add to dashboard Cite

Endovascular aneurysm repair (EVAR) has quickly gained popularity for infrarenal abdominal aortic aneurysm repair during the last two decades. The improvement of available EVAR devices is critical for the advancement of patient care in vascular surgery. Problems are still associated with the grafts, many of which can necessitate the conversion of the patient to open repair, or even result in rupture of the aneurysm. This review attempts to address these problems, by highlighting why they occur and what the failings of the currently available stent grafts are, respectively. In addition, the review gives critical appraisal as to the novel methods required for dealing with these problems and identifies the new generation of stent grafts that are being or need to be designed and constructed in order to overcome the issues that are associated with the existing first- and second-generation devices.

show abstract

Update on the Talent aortic stent-graft: A preliminary report from United States phase I and II trials

Abstract: The Talent stent-graft can be deployed successfully and achieves endovascular exclusion in a large proportion of patients with AAA. Morbidity and mortality rates are acceptable. One-year clinical results and the comparison with concurrent surgical control subjects remain to be evaluated.

Cited by 92 publications

References 4 publications

Suprarenal Fixation of Endograft in Abdominal Aortic Aneurysm Treatment

Suprarenal Fixation of Endograft in Abdominal Aortic Aneurysm Treatment

Risk-Adjusted Outcome Analysis of Endovascular Abdominal Aortic Aneurysm Repair in a Large Population:How Do Stent-Grafts Compare?

AAA Stent–Grafts: Past Problems and Future Prospects

Contact Info

Product

Resources

About